Equity Details
Price & Market Data
Price: $0.0111
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $9,501
Daily Volume: 0
About Trevena, Inc. (TRVN)
Detailed insights into Trevena, Inc. (TRVN)'s trading. Current price: 0.0111, daily change: $0.00 / 0.00%. Market cap: 9,501. All long-term performance metrics, including 6-month and 1-year, are presented here.
Details
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.